Point of Care Testing of Cholinesterase Activity During Burn- and Polytrauma
POCCET
1 other identifier
observational
85
1 country
1
Brief Summary
Goal of this study is to measure serum cholinesterase activity in patients with traumatic and/or burns injury admitted to the emergency room by using point-of- care-test system (POCT). Serum cholinesterase activity, measured using POCT system, might play an important role in the early diagnosis and prediction of patient outcome in trauma-induced systemic inflammation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2016
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2016
CompletedFirst Submitted
Initial submission to the registry
February 16, 2016
CompletedFirst Posted
Study publicly available on registry
February 25, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2018
CompletedApril 16, 2019
April 1, 2019
2 years
February 16, 2016
April 15, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Early diagnosis of the systemic inflammation by using the serum cholinesterase activity measurement
By using Point-of-care measurement of serum cholinesterase activity (U/l) and by observing a change in the enzyme activity over time (reduction of serum cholinesterase activity within the first 6 hours after traumatic injury) would allow an additional tool in early diagnosis and treatment of systemic inflammation.
after completed patient recruitment, 1 year
Secondary Outcomes (1)
correlation of the cholinesterase activity and the trauma/disease severity scores
after completed patient recruitment, 1 year
Study Arms (2)
polytrauma patients
Patients with severe traumatic injury, admitted to the emergency unit. Serum cholinesterase activity measurement using 10 µl whole blood, otherwise obtained through routine blood gas analysis upon arrival to the hospital.
burns patients
Patients with burns trauma, admitted to the emergency unit. Serum cholinesterase activity measurement using 10 µl whole blood, otherwise obtained through routine blood gas analysis upon arrival to the hospital.
Eligibility Criteria
Patients admitted to the emergency unit of the trauma and burns center
You may qualify if:
- signed written consent
- years and older
- severe trauma (ISS \> 15)
- burns injury (2. degree more than 15% body surface or 3 degree more than 10% body surface)
- SIRS
You may not qualify if:
- failure to adhere
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital Heidelberglead
- BG Trauma Center Ludwigshafencollaborator
Study Sites (1)
Department of Anaesthesia, Intensive Care Medicine and Pain Therapy, BG Trauma Center Ludwigshafen
Ludwigshafen am Rhein, Rhineland-Palatinate, 67071, Germany
Biospecimen
A miniature amount (10 μl) of whole blood is needed for the serum cholinesterase activity analysis. This blood specimen will be taken from otherwise routine blood gas analysis collection, taken upon arrival into the emergency room, as a part of the standardized ICU diagnostic and therapeutic procedure. The serum cholinesterase activity analysis, therefore, doesn't require additional blood collection.
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Stefan Hofer, Prof. Dr.
Department of Anesthesiology, Heidelberg University Hospital
- STUDY CHAIR
Stefan Kleinschmidt, Prof. Dr.
Department of Anaesthesia, Intensive Care Medicine and Pain Therapy, BG Trauma Centre Ludwigshafen, Ludwigshafen, Germany
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr. med. Aleksandar Zivkovic
Study Record Dates
First Submitted
February 16, 2016
First Posted
February 25, 2016
Study Start
February 1, 2016
Primary Completion
February 1, 2018
Study Completion
October 1, 2018
Last Updated
April 16, 2019
Record last verified: 2019-04
Data Sharing
- IPD Sharing
- Will not share